Company: INTS
Filing Date: 2025-04-25
Form Type: 424B4
Source: 0001628280-25-020056
Chunk: 28

Company: INTENSITY THERAPEUTICS, INC.
Filing Date: 2025-04-25
Form: 424B4
Chunk 28
---
30th Floor, New York, NY 10004-1561.

<div align='center'>19</div>

### DESCRIPTION OF SECURITIES TO BE REGISTERED
We are offering 3,133,333 shares of Common Stock, along with Common Warrants to purchase up to 6,266,666 shares of Common Stock. Each share of Common Stock is being sold together with a Common Warrant to purchase one share of Common Stock. The shares of Common Stock and accompanying Common Warrants will be issued separately. We are also registering the shares of Common Stock issuable from time to time upon exercise of the Common Warrants offered hereby.

#### Common Stock
See the description above under “Description of Our Capital Stock—Common Stock”.

Series B-1 Common Warrants to be Issued in this Offering

The following is a summary of the material terms and provisions of the Series B-1 Common Warrants that are being offered hereby. This summary is subject to and qualified in its entirety by the form of Series B-1 Common Warrant, which will be filed with the SEC as an exhibit to a Current Report on Form 8-K in connection with this offering and incorporated by reference into the registration statement of which this prospectus supplement and the accompanying prospectus form a part. Prospective investors should carefully review the terms and provisions of the form of warrant for a complete description of the terms and conditions of the warrants.

#### Duration and Exercise Price.
The Series B-1 Common Warrants offered hereby will have an exercise price of $0.85 per share. The Series B-1 Common Warrants are immediately exercisable, at an exercise price equal to $0.85 per share. The Series B-1 Common Warrants will expire five years from issuance. The exercise price and number of shares of Common Stock issuable upon exercise of the Series B-1 Common Warrants are subject to appropriate adjustment in the event of stock dividends, stock splits, reorganizations or similar events affecting our Common Stock.

#### Exercisability.
The Series B-1 Common Warrants will be immediately exercisable, at the option of each holder, in whole or in part, by delivering a duly executed exercise notice accompanied by payment in full for the number of shares of our Common Stock purchased upon such exercise (except in the case of a cashless exercise as discussed below).

#### Exercise Limitations.
We may not effect the exercise of any Series B-1 Common Warrant, and a holder will not be entitled to exercise any portion of any